| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 14
| Issue : 2 | Page : 161-164 |
|
|
Mucormycosis: An emerging concern of orofacial complication in COVID-19 infection
Anam Mushtaq, Reshi Iram Shafi
Department of Pediatric and Preventive Dentistry, ITS Dental College, Hospital and Research Centre, Greater Noida, Uttar Pradesh, India
Correspondence Address:
Anam Mushtaq
Department of Pediatric and Preventive Dentistry, ITS Dental College, Hospital and Research Centre, Greater Noida, Uttar Pradesh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jorr.jorr_72_21
|
|
|
Coronavirus disease (COVID-19) infection has been seen to be associated with secondary bacterial and fungal infections. Mucormycosis has been increasingly reported in patients with COVID-19 infection, especially those with underlying medical conditions such as diabetes mellitus and on steroid therapy. It is an acute invasive fungal infection primarily affecting individuals with suppressed immune system. This article presents the characteristics of mucormycosis infection and its etiological association with COVID-19. Its diagnosis and management based on the current guidelines have also been discussed in this literature review.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
